Routine use of gemtuzumab ozogamicin in 7 + 3-based inductions for all 'non-adverse' risk AML
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:62 |
---|---|
Enthalten in: |
Leukemia & lymphoma - 62(2021), 6 vom: 25. Juni, Seite 1510-1513 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Ladha, Abdullah [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 24.06.2021 Date Revised 24.06.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/10428194.2021.1876869 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM320536106 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM320536106 | ||
003 | DE-627 | ||
005 | 20231225173806.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/10428194.2021.1876869 |2 doi | |
028 | 5 | 2 | |a pubmed24n1068.xml |
035 | |a (DE-627)NLM320536106 | ||
035 | |a (NLM)33491527 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Ladha, Abdullah |e verfasserin |4 aut | |
245 | 1 | 0 | |a Routine use of gemtuzumab ozogamicin in 7 + 3-based inductions for all 'non-adverse' risk AML |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 24.06.2021 | ||
500 | |a Date Revised 24.06.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Letter | |
650 | 7 | |a Aminoglycosides |2 NLM | |
650 | 7 | |a Gemtuzumab |2 NLM | |
650 | 7 | |a 93NS566KF7 |2 NLM | |
700 | 1 | |a Hui, Gavin |e verfasserin |4 aut | |
700 | 1 | |a Cheung, Edna |e verfasserin |4 aut | |
700 | 1 | |a Berube, Caroline |e verfasserin |4 aut | |
700 | 1 | |a Coutre, Steven E |e verfasserin |4 aut | |
700 | 1 | |a Gotlib, Jason |e verfasserin |4 aut | |
700 | 1 | |a Liedtke, Michaela |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Tian Y |e verfasserin |4 aut | |
700 | 1 | |a Muffly, Lori |e verfasserin |4 aut | |
700 | 1 | |a Mannis, Gabriel N |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Leukemia & lymphoma |d 1989 |g 62(2021), 6 vom: 25. Juni, Seite 1510-1513 |w (DE-627)NLM012624047 |x 1029-2403 |7 nnns |
773 | 1 | 8 | |g volume:62 |g year:2021 |g number:6 |g day:25 |g month:06 |g pages:1510-1513 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/10428194.2021.1876869 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 62 |j 2021 |e 6 |b 25 |c 06 |h 1510-1513 |